Skip to content

Charles River Laboratories CRL Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Revvity logo
RevvityRVTY
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
IQVIA logo
IQVIAIQV
Danaher logo
DanaherDHR
Agilent Technologies logo
Agilent TechnologiesA
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's common stock, par value (in dollars per share)?
Charles River Laboratories (CRL) reported common stock, par value (in dollars per share) of $0.01 in Q1 2026.
How has Charles River Laboratories's common stock, par value (in dollars per share) changed year-over-year?
Charles River Laboratories's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
What is the long-term trend for Charles River Laboratories's common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), Charles River Laboratories's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.